Concepedia

Cheng Ma

CM

Statistics

Publications

11

Citations

433

H-Index

11

Active since

2021

Affiliations

Chengdu University of Traditional Chinese Medicine(Current)

Southwestern Institute of Physics

Cheng Ma is an author at Chengdu University of Traditional Chinese Medicine specializing in pharmacology, hepatic fibrosis, and liver disease.

ORCID

Publications per year

2021–2023

11

Publications

11

CD44‐Targeting Drug Delivery System of Exosomes Loading Forsythiaside A Combats Liver Fibrosis via Regulating NLRP3‐Mediated Pyroptosis

Lihong Gong, Honglin Zhou, Shenglin Zhang et al. · Advanced Healthcare Materials · 2023 · 82 citations · Full text

, , +17

Phillygenin Attenuates Carbon Tetrachloride-Induced Liver Fibrosis via Modulating Inflammation and Gut Microbiota

Cheng Wang, Cheng Ma, Ke Fu et al. · Frontiers in Pharmacology · 2021 · 65 citations · Full text

, , +17

Phillygenin inhibited M1 macrophage polarization and reduced hepatic stellate cell activation by inhibiting macrophage exosomal miR-125b-5p

Cheng Ma, Cheng Wang, Yafang Zhang et al. · Biomedicine & Pharmacotherapy · 2023 · 58 citations · Full text

, , +17

Forsythiaside A alleviated carbon tetrachloride-induced liver fibrosis by modulating gut microbiota composition to increase short-chain fatty acids and restoring bile acids metabolism disorder

Ke Fu, Cheng Ma, Cheng Wang et al. · Biomedicine & Pharmacotherapy · 2022 · 55 citations · Full text

, , +17

Carthami flos extract against carbon tetrachloride-induced liver fibrosis via alleviating angiogenesis in mice

Xinyan Xue, Xingtao Zhao, Jing Wang et al. · Phytomedicine · 2022 · 41 citations

, , +10

1–5 of 11